Specialized cell-free DNA blood collection tubes

Pre-analytical blood collection tubes specifically for liquid biopsy, validated for collection of whole blood and stabilization of cfDNA and ctDNA for up to 21 days.

Scalable, automatable cfDNA extraction

A flexible and efficient cfDNA extraction kit that uses paramagnetic beads to obtain high quality cfDNA from plasma or serum

Efficient cell-free DNA (cfDNA) extraction

The Cell3™ Xtract kit enables fast and flexible extraction of cell free DNA (cfDNA) from a range of biological samples ensuring high quality cfDNA & ctDNA for research and clinical applications.

Comprehensive capture for hereditary cancer analysis

Confidently call all variants including SNVs, indels and CNVs in 129 genes associated with hereditary cancer.

Comprehensive NGS panel for translational and clinical research into urothelial bladder cancer (UBC)

Targeting 451 somatic mutations found in 96% of bladder cancer cases, this panel has the potential to offer a non-invasive alternative to cytoscopy via urinary DNA analysis.

Tumor exome sequencing

Whole exome capture with extensive clinically relevant content for comprehensive primary tumor sequencing.

Comprehensive cancer mutation, TMB and MSI analysis

Comprehensive cancer mutation analysis providing robust calling of SNVs, indels and CNVs, as well as TMB and MSI across 524 oncogenes using a single NGS enrichment workflow.

Whole exome sequencing

Optimised whole exome coverage delivering higher sample throughput and reducing sequencing costs.

Custom NGS panels for rare variant detection

Targeted resequencing using innovative Cell3™ Target technology to convert any type of DNA (cfDNA, gDNA, FFPE DNA) into libraries for NGS.

Analyze actionable mutations in the EGFR pathway

Detect low frequency variants in key oncogenes of the Epidermal Growth Factor Receptor (EGFR) pathway using genomic DNA (gDNA) or cell free DNA (cfDNA) from primary tumours or liquid biopsies.

Longitudinal Monitoring for Minimal Residual Disease

Small, ultrasensitive, personalized NGS panels for detecting tumor specific variants at multiple time points

Detect SNVs, indels and CNVs in a single, clinical-grade assay

Capture more variants and increase your diagnostic yield without increasing your sequencing costs.

Exome capture for cytogenomic analysis

Clinically enhanced human exome capture enabling detection of SNVs, indels and CNVs in a single assay.

Whole exome sequencing

Optimised whole exome coverage delivering higher sample throughput and reducing sequencing costs.

Carrier Screening for paediatric recessive disorders

Accurately analyse carrier status of 448 inherited childhood disorders using a single workflow

Detect all known COVID-19 variants

Viral RNA extraction and qRT-PCR workflow for detection of SARS-CoV-2 (COVID-19) using our VirPath product range.

Differentiate COVID-19, flu and RSV in one assay

Highly sensitive and simple to use real-time RT-PCR assay designed for simultaneous detection of SARS-CoV-2, influenza type A/B and Respiratory syncytical virus (RSV) subtypes A and B